Prognostic and predictive factors of eribulin efficacy in heavily pretreated patients affected by metastatic breast cancer: correlation with tumor biology and previous therapies

BACKGROUND: Eribulin mesylate is currently approved in the United States and Europe for the treatment of metastatic breast cancer (MBC). SCOPE: The objective of this retrospective study is to find specific predictive criteria related to patient or tumor characteristics in order to select patients th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drugs Context
Main Authors: Rossi, Sabrina, Cassano, Alessandra, Strippoli, Antonia, Schinzari, Giovanni, D’Argento, Ettore, Basso, Michele, Barone, Carlo
Format: Artigo
Sprog:Inglês
Udgivet: BioExcel Publishing Ltd 2017
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5699107/
https://ncbi.nlm.nih.gov/pubmed/29167692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212506
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker